We and others have previously described that AnxA1 is an effective mediator of inflammation resolution involved in various preclinical models of inflammatory diseases such as gout, pleurisy, peritonitis, and arthritis [33,42,43,44,45]. The gene discussed is ANXA1; the disease is gout.